Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 859

2'-fucosyllactose

Intended Use: For use an ingredient in whey, milk, and soy-based, non-exempt infant formulas at a level of 2.4 g/L of formula as consumed; infant and toddler foods at levels ranging from 0.24-1.2 g/serving; and 0 in beverage and beverage bases; breakfast cereals; dairy product analogs; frozen dairy desserts and mixes; gelatins, puddings, and fillings; grain products and pastas; jams and jellies; milk and milk products; processed fruits and fruit juices; and sweet sauces, toppings and syrup at levels ranging from 0.28-1.2 g/serving
Basis: Scientific procedures
Notifier: Advanced Protein Technologies, Corp.
Notifier Address: 5 Mosan-gil, Jeongnam-myeon
Hwasung City, Gyeonggi-do, 18516
Republic of Korea
GRAS Notice (releasable information): GRN 859 (in PDF) (13 MB)
Date of closure: Sep 6, 2019
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (106 kB)
-
-